EUVIMEDEUVIMED entdecken
Crossref

Insights into curcumin’s anticancer activity in pancreatic ductal adenocarcinoma: Experimental and computational evidence targeting HRAS, CCND1, EGFR and AKT1

Jun-Feng Cao, Xiao Zhang, Qingjie Xia, Kuan Hang, Jie Men, Jin Tian, Dunshui Liao, Zengliang Xia, Kezhou Li

Bioorganic Chemistry · 2025-04 · 157 · 108264

DOI: 10.1016/j.bioorg.2025.108264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2025-04. Verfasst von Jun-Feng Cao und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Southwest Jiaotong University, Chengdu 610031 Sichuan, China. Hauptthemen laut MEDLINE: ErbB Receptors, Cyclin D1, Curcumin, Cell Proliferation. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 114 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Curcumin, as a natural polyphenolic compound, possesses antitumor, antioxidant properties and anti-inflammatory. Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor, and there is a lack of molecular mechanisms and therapeutic options regarding relevant therapeutic agents. Therefore, we investigated the mechanism of curcumin inhibiting pancreatic cancer growth by modulating proliferation of cells and cellular metabolism. METHODS: Bioinformatics analysis was involved in analyzing the intersecting targets of curcumin and pancreatic ductal adenocarcinoma. The effect of curcumin on proliferation of PANC-1 cells was tested by CCK-8, and total RNA from PANC-1 was also analysed by transcriptome sequencing. Molecular docking was involved in verifying binding stability of curcumin to protein targets. Molecular dynamics simulated and evaluated binding free energy, hydrogen bonds and root mean square fluctuation of the complex. RESULTS: PPI, GO and KEGG were involved in screening and analysing key interacting protein targets. 40 μg/mL curcumin significantly inhibited the growth and proliferation of PANC-1. Transcriptome sequencing results showed gene expression of Cyclin D1 (CCND1), AKT serine/threonine kinase 1 (AKT1), HRas proto-oncogene (HRAS), epidermal growth factor receptor (EGFR) was significantly down-regulated by curcumin treatment. Result of molecular dynamics and molecular docking inhibited the free binding energies of CCND1/Curcumin, HRAS/Curcumin, AKT1/Curcumin and EGFR/Curcumin were -21.13 ± 3.41 kcal/mol, -21.84 ± 4.38 kcal/mol, -20.61 ± 1.82 kcal/mol and -27.37 ± 1.94 kcal/mol, respectively. CONCLUSION: We found curcumin may not only regulate cell cycle progression in PDAC and apoptosis by down-regulating HRAS, thereby inhibiting CCND1 and its downstream signaling pathways, but also inhibit energy metabolism reprogramming, Ras-RAF-MEK-ERK and other downstream signalling pathways by down-regulating EGFR and AKT1, thereby affecting tumor cell metastasis, survival and proliferation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErbB ReceptorsCyclin D1CurcuminCell ProliferationProto-Oncogene Proteins c-aktAntineoplastic AgentsPancreatic NeoplasmsCarcinoma, Pancreatic DuctalMolecular Docking SimulationProto-Oncogene MasDrug Screening Assays, AntitumorHumansDose-Response Relationship, DrugMolecular StructureStructure-Activity RelationshipProto-Oncogene Proteins p21(ras)Cell Line, TumorMolecular Dynamics Simulation

Stichwörter der Autor:innen

Cellular experimentsCurcuminMolecular dockingMolecular dynamicsPancreatic ductal adenocarcinomaTranscriptome sequencing

Substanzen

ErbB ReceptorsCyclin D1CurcuminProto-Oncogene Proteins c-aktEGFR protein, humanAntineoplastic AgentsCCND1 protein, humanMAS1 protein, humanHRAS protein, humanProto-Oncogene Mas

Autor:innen und Institutionen

  • College of Medicine, Southwest Jiaotong University, Chengdu 610031 Sichuan, China.
  • Chengdu Medical College, Chengdu 610500 Sichuan, China.
  • Institute of Neurological Diseases, Translation Neuroscience Center, West China Hospital, Sichuan University, Chengdu 610041 Sichuan, China.
  • Division of Pancreatic Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu 610041 Sichuan, China.
  • College of Medicine, Southwest Jiaotong University, Chengdu 610031 Sichuan, China; Division of Pancreatic Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu 610041 Sichuan, China. E…

Zitieren

APA

Cao, J. F., Zhang, X., Xia, Q., Hang, K., Men, J., Tian, J., Liao, D., Xia, Z., & Li, K. (2025). Insights into curcumin’s anticancer activity in pancreatic ductal adenocarcinoma: Experimental and computational evidence targeting HRAS, CCND1, EGFR and AKT1. Bioorganic Chemistry, 157, 108264. https://doi.org/10.1016/j.bioorg.2025.108264

Vancouver

Cao JF, Zhang X, Xia Q, Hang K, Men J, Tian J, et al. Insights into curcumin’s anticancer activity in pancreatic ductal adenocarcinoma: Experimental and computational evidence targeting HRAS, CCND1, EGFR and AKT1. Bioorganic Chemistry. 2025;157:108264. doi:10.1016/j.bioorg.2025.108264

BibTeX
@article{Cao2025,
  author = {Cao, Jun-Feng and Zhang, Xiao and Xia, Qingjie and Hang, Kuan and Men, Jie and Tian, Jin and Liao, Dunshui and Xia, Zengliang and Li, Kezhou},
  title = {Insights into curcumin’s anticancer activity in pancreatic ductal adenocarcinoma: Experimental and computational evidence targeting HRAS, CCND1, EGFR and AKT1},
  journal = {Bioorganic Chemistry},
  year = {2025},
  volume = {157},
  pages = {108264},
  doi = {10.1016/j.bioorg.2025.108264}
}
Kostenlos starten →